{"info": {"address1": "2000 16th Street", "city": "Denver", "state": "CO", "zip": "80202", "country": "United States", "phone": "720 631 2100", "website": "https://www.davita.com", "industry": "Medical Care Facilities", "sector": "Healthcare", "longBusinessSummary": "DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.", "fullTimeEmployees": 70000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Javier J. Rodriguez", "age": 51, "title": "CEO & Exec. Director", "yearBorn": 1971, "fiscalYear": 2021, "totalPay": 3298439, "exercisedValue": 5948923, "unexercisedValue": 5951718}, {"maxAge": 1, "name": "Mr. Joel  Ackerman", "age": 57, "title": "CFO & Treasurer", "yearBorn": 1965, "fiscalYear": 2021, "totalPay": 1430448, "exercisedValue": 9330821, "unexercisedValue": 1336423}, {"maxAge": 1, "name": "Ms. Kathleen Alyce Waters", "age": 54, "title": "Chief Legal & Public Affairs Officer", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": 1275853, "exercisedValue": 1149936, "unexercisedValue": 1812315}, {"maxAge": 1, "name": "Mr. James O. Hearty", "age": 53, "title": "Chief Compliance Officer", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": 891579, "exercisedValue": 150514, "unexercisedValue": 2267634}, {"maxAge": 1, "name": "Mr. Michael David Staffieri", "age": 48, "title": "Chief Operating Officer of Kidney Care", "yearBorn": 1974, "fiscalYear": 2021, "totalPay": 1975021, "exercisedValue": 2524352, "unexercisedValue": 11926198}, {"maxAge": 1, "name": "Mr. Jim  Gustafson", "title": "VP of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth Gardner Smith", "age": 41, "title": "Chief People Officer", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abdulkareem  Alsuwaida FRCPC, M.D., MSc", "title": "Chief Medical Officer - Saudi Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dinesh M. Kumar M.D.", "age": 53, "title": "Sr. VP of Clinical Transformation", "yearBorn": 1969, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Misha  Palecek", "title": "Chief Transformation Officer of HealthCare Partners", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 4, "governanceEpochDate": 1680307200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400, "priceHint": 2, "previousClose": 83.86, "open": 84.01, "dayLow": 83.05, "dayHigh": 84.07, "regularMarketPreviousClose": 83.86, "regularMarketOpen": 84.01, "regularMarketDayLow": 83.05, "regularMarketDayHigh": 84.07, "payoutRatio": 0.0, "beta": 0.932525, "trailingPE": 14.698944, "forwardPE": 11.825779, "volume": 388419, "regularMarketVolume": 388419, "averageVolume": 643060, "averageVolume10days": 461810, "averageDailyVolume10Day": 461810, "bid": 0.0, "ask": 85.0, "bidSize": 1300, "askSize": 800, "marketCap": 7547495936, "fiftyTwoWeekLow": 65.28, "fiftyTwoWeekHigh": 124.81, "priceToSalesTrailing12Months": 0.6500917, "fiftyDayAverage": 80.8506, "twoHundredDayAverage": 81.9419, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 20603168768, "profitMargins": 0.048270002, "floatShares": 89692168, "sharesOutstanding": 90400000, "sharesShort": 3026159, "sharesShortPriorMonth": 2934435, "sharesShortPreviousMonthDate": 1677542400, "dateShortInterest": 1680220800, "sharesPercentSharesOut": 0.0335, "heldPercentInsiders": 0.0318, "heldPercentInstitutions": 0.88762003, "shortRatio": 4.3, "shortPercentOfFloat": 0.056199998, "impliedSharesOutstanding": 0, "bookValue": 7.879, "priceToBook": 10.596522, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "earningsQuarterlyGrowth": -0.637, "netIncomeToCommon": 546947968, "trailingEps": 5.68, "forwardEps": 7.06, "pegRatio": -8.1, "lastSplitFactor": "2:1", "lastSplitDate": 1378684800, "enterpriseToRevenue": 1.775, "enterpriseToEbitda": 10.074, "52WeekChange": -0.32331008, "SandP52WeekChange": -0.06829989, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "DVA", "underlyingSymbol": "DVA", "shortName": "DaVita Inc.", "longName": "DaVita Inc.", "firstTradeDateEpochUtc": 815149800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9a98f945-67ed-31a1-b380-e8d4ee6cc270", "messageBoardId": "finmb_35644", "gmtOffSetMilliseconds": -14400000, "currentPrice": 83.49, "targetHighPrice": 102.0, "targetLowPrice": 74.0, "targetMeanPrice": 87.49, "targetMedianPrice": 87.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 8, "totalCash": 321779008, "totalCashPerShare": 3.56, "ebitda": 2045144064, "totalDebt": 11822489600, "quickRatio": 1.096, "currentRatio": 1.204, "totalRevenue": 11609893888, "debtToEquity": 531.396, "revenuePerShare": 124.848, "returnOnAssets": 0.04818, "returnOnEquity": 0.3343, "grossProfits": 3400341000, "freeCashflow": 832265344, "operatingCashflow": 1564569984, "earningsGrowth": -0.589, "revenueGrowth": -0.009, "grossMargins": 0.29288, "ebitdaMargins": 0.17616, "operatingMargins": 0.11305001, "financialCurrency": "USD", "trailingPegRatio": 1.5483}, "news": [{"uuid": "351e8413-ae6f-34ef-b422-46ae5bde823b", "title": "DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/davita-inc-schedules-1st-quarter-173000729.html", "providerPublishTime": 1681839000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Ft8_lSztefdUeKH_KWZOA--~B/aD0xNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6c51fd59e8011e77088a18c2147ba51f", "width": 400, "height": 150, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gWaXDdGzsyZoPNEEMAh8ug--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/6c51fd59e8011e77088a18c2147ba51f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DVA"]}, {"uuid": "a0e3ab77-ba76-37ae-a187-2fdfd6d1e88c", "title": "Warren Buffett Owns More Than a 23% Stake in These 3 Stocks", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/a0e3ab77-ba76-37ae-a187-2fdfd6d1e88c/warren-buffett-owns-more-than.html", "providerPublishTime": 1681465680, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cZdRbDax73PmYZgzvVxRtw--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/3c0edaf928b625a064cf06ed75764f54", "width": 2048, "height": 1365, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dh.IZ5BtLNX3sOXQ5Lt7CQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/3c0edaf928b625a064cf06ed75764f54", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["KHC", "DVA", "OXY"]}, {"uuid": "fcfc2766-435e-3ae0-a510-fb9f1cb1ab01", "title": "Medtronic (MDT) Launches New Venture to Treat Kidney Failure", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/medtronic-mdt-launches-venture-treat-153403548.html", "providerPublishTime": 1680536043, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zI61SzJlE3DzdNNCKbWKhw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b7e497ea000cb0cc6dfcdc3b4048a92c", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fR3lo3Xw5aV.z3zA8WxDEg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b7e497ea000cb0cc6dfcdc3b4048a92c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MDT", "DVA", "HOLX", "AVNS"]}, {"uuid": "f8ccf836-4b22-3329-9505-e498ebd44b2e", "title": "Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure", "publisher": "CNW Group", "link": "https://finance.yahoo.com/news/medtronic-davita-launch-mozarc-medical-160000529.html", "providerPublishTime": 1680364800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/V7CQo9BedcTkPh5DzTPzEQ--~B/aD01NDt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/cnwgroup.com/8bd10b47cc2ba817ba75c96449e46d28", "width": 400, "height": 54, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XRChvHPAdANrX34xCwT9aQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cnwgroup.com/8bd10b47cc2ba817ba75c96449e46d28", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DVA", "MDT"]}, {"uuid": "474dc6c2-ccc1-389d-80b6-e0216b9651ff", "title": "3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/3-reasons-retain-davita-dva-155803560.html", "providerPublishTime": 1680278283, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/noQD.zOKRH2xEVN8Fe5Nuw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ccbb2e1d18369689ff78c27076e55307", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/kyaGvaSA_umpLy5JR89goA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/ccbb2e1d18369689ff78c27076e55307", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DVA", "HOLX", "AVNS"]}, {"uuid": "fccf1713-a3cb-3362-9a7e-292de22fe068", "title": "13 Best Medical Stocks To Invest In", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/13-best-medical-stocks-invest-235023832.html", "providerPublishTime": 1680133823, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SxYiR4WqYnI_sSqX5ssRbw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a4e92fdf299feff482bb5196b9780f09", "width": 1000, "height": 667, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YKJDf0CVPFt5vIRAwU2_Qw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a4e92fdf299feff482bb5196b9780f09", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DVA", "ALGN", "ABC", "AMN", "CAH", "MCK", "BSX", "BIO-B", "ABT"]}, {"uuid": "2cfbf11c-433b-3baf-8f2a-3a8cb4745aa3", "title": "DaVita (NYSE:DVA) investors are sitting on a loss of 33% if they invested a year ago", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/davita-nyse-dva-investors-sitting-135146661.html", "providerPublishTime": 1680097906, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3KT0PYS0wD1QPsJRG80v4w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DVA"]}, {"uuid": "fd20a7b2-3ae3-38c4-9fdd-15c81ba12815", "title": "Aerospace Executives Go to Trial Over Alleged No-Poach Deals", "publisher": "The Wall Street Journal", "link": "https://finance.yahoo.com/m/fd20a7b2-3ae3-38c4-9fdd-15c81ba12815/aerospace-executives-go-to.html", "providerPublishTime": 1679835600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/lTD8GTJg25AAtEaGFXxgWQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/12403f9e150d793a5d98f38661dc9743", "width": 1280, "height": 640, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9yIbnOoQYXxGEo0TA0TjJQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/12403f9e150d793a5d98f38661dc9743", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["RTX", "DVA"]}]}